Early antimicrobial therapy and clinical outcomes of left-sided Enterococcus faecalis endocarditis: a NIDUS registry study

Abstract Purpose Antimicrobial therapy of Enterococcus faecalis endocarditis treatment is challenged by high intrinsic resistance and relapse rates. Knowledge on practice patterns is warranted. We aimed to describe early-phase monotherapy and combination therapy use in E. faecalis endocarditis treatment. Methods This retrospective, nationwide cohort study was conducted in Denmark between 2016 and 2021. All patients with left-sided E. faecalis endocarditis were derived from the NatIonal Danish endocarditis stUdieS registry (NIDUS). Antimicrobial therapy during the first 10 days was compared between monotherapy and combination therapy. The groups were compared by in-hospital mortality, acute kidney injury and surgery with logistic regression and 6-month relapse and recurrence rate and 6-month mortality rate with Kaplan-Meier estimates and multivariable cox regression. Results We included 392 patients, 59(15.1%) received monotherapy and 333 (84.9%) combination therapy. Patients in monotherapy were older (median 79.3 versus 76.0 years) and had more comorbidities. Monotherapy comprised ampicillin (74.6%), vancomycin (16.9%) and penicillin (6.8%). Among combination regimens the most frequent were ampicillin +gentamicin (65.4%), ampicillin + linezolid (6.6%) and ampicillin + ceftriaxone (5.1%). Surgical rates were comparable. Acute kidney injury during admission occurred in 20.7% versus 16.6% patients. No significant difference in relapse (5.9% versus 8.5%) or recurrence rates (5.4% versus 6.8%) was found. Similar in-hospital mortality (13.8% vs. 11.9%) and 6-month mortality rates were seen in the monotherapy and combination therapy groups. Conclusion The most common treatment of E. faecalis endocarditis was combination therapy, however certain selected patients were treated with monotherapy with similar outcomes. Use of monotherapy remains controversial and would need testing in a controlled randomized setting.

Authors

Institutions

Publication Details

Journal
Infection
Published
2026-10-03
DOI
https://doi.org/10.1007/s15010-026-02974-w
Primary Topic
Infective Endocarditis Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early antimicrobial therapy and clinical outcomes of left-sided Enterococcus faecalis endocarditis: a NIDUS registry study

Jannik Helweg‐Larsen, Jonas Agerlund Povlsen, Peter Godsk Jørgensen, Louise Marqvard Sørensen et al.
Infection
Infective Endocarditis Diagnosis and Management
article

Early antimicrobial therapy and clinical outcomes of left-sided Enterococcus faecalis endocarditis: a NIDUS registry study

Jannik Helweg‐Larsen, Jonas Agerlund Povlsen, Peter Godsk Jørgensen, Louise Marqvard Sørensen, Katra Hadji-Turdeghal, Daniel Faurholt‐Jepsen, Lars Køber, Peter Laursen Graversen, Claus Ernst Moser, Niels Eske Bruun, Henning Bundgaard, Anders Dahl, Søren Fanø, Morten Holdgaard Smerup, Emil Loldrup Fosbøl, Kasper Karmark Iversen, Lauge Østergaard, Jacob Eifer Møller, Anna Ståhl, Ida Holm Jessen Knudsen
article en

Abstract

Abstract Purpose Antimicrobial therapy of Enterococcus faecalis endocarditis treatment is challenged by high intrinsic resistance and relapse rates. Knowledge on practice patterns is warranted. We aimed to describe early-phase monotherapy and combination therapy use in E. faecalis endocarditis treatment. Methods This retrospective, nationwide cohort study was conducted in Denmark between 2016 and 2021. All patients with left-sided E. faecalis endocarditis were derived from the NatIonal Danish endocarditis stUdieS registry (NIDUS). Antimicrobial therapy during the first 10 days was compared between monotherapy and combination therapy. The groups were compared by in-hospital mortality, acute kidney injury and surgery with logistic regression and 6-month relapse and recurrence rate and 6-month mortality rate with Kaplan-Meier estimates and multivariable cox regression. Results We included 392 patients, 59(15.1%) received monotherapy and 333 (84.9%) combination therapy. Patients in monotherapy were older (median 79.3 versus 76.0 years) and had more comorbidities. Monotherapy comprised ampicillin (74.6%), vancomycin (16.9%) and penicillin (6.8%). Among combination regimens the most frequent were ampicillin +gentamicin (65.4%), ampicillin + linezolid (6.6%) and ampicillin + ceftriaxone (5.1%). Surgical rates were comparable. Acute kidney injury during admission occurred in 20.7% versus 16.6% patients. No significant difference in relapse (5.9% versus 8.5%) or recurrence rates (5.4% versus 6.8%) was found. Similar in-hospital mortality (13.8% vs. 11.9%) and 6-month mortality rates were seen in the monotherapy and combination therapy groups. Conclusion The most common treatment of E. faecalis endocarditis was combination therapy, however certain selected patients were treated with monotherapy with similar outcomes. Use of monotherapy remains controversial and would need testing in a controlled randomized setting.

Infection
University of Copenhagen (DK), Amager Hospital (DK), Odense University Hospital (DK), Herlev Hospital (DK), Aarhus University Hospital (DK), Copenhagen University Hospital (DK), Gentofte Hospital (DK), Zealand University Hospital (DK)
Openalex Percentile: Top 11%
Infective Endocarditis Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.